Kabak Amanda 4
4 · CLEANSPARK, INC. · Filed Oct 28, 2020
Insider Transaction Report
Form 4
CLEANSPARK, INC.CLSK
Kabak Amanda
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-10-26+20,000→ 20,000 totalExercise: $9.00Exp: 2023-10-25→ Common Stock (20,000 underlying) - Award
Stock Option (Right to Buy)
2020-10-26+5,000→ 5,000 totalExercise: $9.00From: 2020-10-26Exp: 2023-10-25→ Common Stock (5,000 underlying) - Award
Common Stock
2020-10-26+13,000→ 13,000 total - Award
Common Stock
2020-10-26+15,000→ 28,000 total
Footnotes (4)
- [F1]On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 13,000 shares of common stock to Ms. Kabak under the issuer's equity incentive plan as a bonus for fiscal year 2020. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share.
- [F2]On October 26, 2020, the compensation committee of the board of directors of the issuer approved an issuance of 15,000 shares of restricted common stock to Ms. Kabak under the issuer's equity incentive plan which shares vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The shares were valued at the closing traded price of the Company's common stock on October 26, 2020 of $8.07 per share.
- [F3]On October 26, 2020, the compensation committee of the board of directors of the issuer approved the grant of an option to purchase 5,000 shares of common stock to Ms. Kabak under the issuer's equity incentive plan as a bonus for fiscal year 2020 ended September 30, 2020. The options were fully vested on grant and were granted at an exercise price of $9.00 per share.
- [F4]On October 26, 2020, the compensation committee of the board of directors of the issuer approved the grant of an option to purchase 20,000 shares of common stock to Ms. Kabak under the issuer's equity incentive plan which options vest pursuant to certain corporate milestones of the issuer for fiscal year 2021. The options were granted with an exercise price of $9.00 per share.